San Francisco Welcomes BioPharm America™ and ChinaBio® Day
San Francisco Welcomes BioPharm America™ and ChinaBio® Day
Leaders of the international bio-pharmaceutical industry come to the birthplace of biotech for three days of high level networking and dealmaking
Carlsbad and Boston, MA, USA; July 28, 2009: Leaders from the city of San Francisco and luminaries from both the California and the international biotech and pharmaceutical industry today officially welcomed the BioPharm America™ 2009 and ChinaBio® Day conferences. To be held at the San Francisco Marriott, from September 15–18, 2009, the events will bring together decision makers from all sectors of the international bio-pharmaceutical industry for three days of high level networking and dealmaking.
These unique partnering events are specially designed to facilitate collaborations between regional biotech firms and global industry players such as AstraZeneca, Bayer Schering, Exelixis, Genentech, Gilead, Johnson & Johnson, Merck & Co., Inc., Pfizer, Takeda and UCB. With an additional emphasis on China, the partnerships developed from these events will help ignite new ideas and business opportunities resulting in future healthcare innovations.
Now in its second year, BioPharm America is based on the formula used by the largest biotech partnering events in Europe–BIO-Europe and BIO-Europe Spring®–that have generated in the past year over 17,000 one-to-one business meetings largely between biotech firms and pharma companies.
Michael Cohen, Director, San Francisco Economic and Workforce Development, said, "We are excited to host BioPharm America and ChinaBio Day. As a city that pushes the forefront of biotech innovation, it is essential that we actively engage and host events such as these, to facilitate the collaboration needed for the continued strength of our biotech industry."
The events utilize specially designed software called partneringONE™ developed by EBD Group that makes identifying and meeting with potential business opportunities easy. partneringONE is the matchmaking engine for eighteen life science events around the world, including EBD Group's own events BIO-Europe, BIO-Europe Spring, BioPharm America, EuroMedtech™ and ChinaBio Partnering Forum. In the past year alone partneringONE has generated over 25,000 one-to-one meetings between companies across all sectors of the biotech and medtech industry value chain.
"We are honored to hold the BioPharm America, ChinaBio Day events in the dynamic city of San Francisco, which will also be home to our biotech investor conference, Biotech Showcase™, in January 2010," said Carola Schropp, President, EBD Group.
"Already home to some of the world's most innovative and successful biotech companies, EBD Group looks forward to helping the region assert its leadership role in the biotech industry. In the US, BioPharm America is unique in bringing together industry dealmakers in a forum specially designed to facilitate new strategic partnerships," Schropp added.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
BD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences at industry events.
Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com or contact:
Constantine Theodoropulos
EBD Group
+1 617 816 4637
ctheodoropulos@ebdgroup.com
About MassBio
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
For more information please visit www.massbio.org.
